PRTODAY / NewswireToday Free press release distribution service network

Written by / Agency / Source: The Scott Partnership

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

CEO of Molecular Profiles Recognized as One of 100 Most Inspiring People in Life Sciences Industry - Molecular Profiles, a leading provider of pharmaceutical development services, announces that Nikin Patel, CEO, has been acknowledged as one of PharmaVOICE magazine’s top 100 most inspiring individuals in the life sciences industry
CEO of Molecular Profiles Recognized as One of 100 Most Inspiring People in Life Sciences Industry

 

NewswireToday - /newswire/ - Nottingham, United Kingdom, 2011/08/05 - Molecular Profiles, a leading provider of pharmaceutical development services, announces that Nikin Patel, CEO, has been acknowledged as one of PharmaVOICE magazine’s top 100 most inspiring individuals in the life sciences industry.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Dr. Patel has been recognized for his 13 years of dedicated commitment to advancing pharmaceutical technology that has seen him co-found a company infused with his own brand of innovative problem solving and new industry techniques. The PharmaVOICE 100 winners are nominated by the magazine’s readers, who identify the individuals they consider to have the most influence and positive impact on leadership, research and development, technology, creativity, marketing and business strategies.

“I feel incredibly honoured to be receiving this award,” said Dr.Patel. “But I have to add that it would not have been possible without my talented and inspiring colleagues. This award is very gratifying, and my team and I will continue the hard work to improve and add to our portfolio of services for the pharmaceutical industry.”

After gaining a first class honours degree and doctorate in Pharmacy from the University of Nottingham, Dr. Patel and his PhD supervisors founded Molecular Profiles in 1997 to provide high-end pharmaceutical analysis. Since the company’s inception it has grown into a recognized contract research provider, successfully servicing multinational pharmaceutical companies and supporting the development of novel drugs. Molecular Profiles continues to improve and expand its formulation capabilities, such as through its recent purchase of the Xcelodose system, making it one of very few organizations to offer this time-scale reducing technology.

Dr. Patel’s leadership and contribution to the organization have previously been recognized through the UK’s most prestigious industry accolade, the Queen’s Award for Enterprise, won by Molecular Profiles both in 2007 and 2011 in the Innovation category. These awards highlight Molecular Profiles’ advances in pharmaceutical development.

Dr. Patel’s considerable expertise in pharmaceutical technology means that he has been invited to present papers, speak at conferences and present to pharmaceutical companies around the world. Dr. Patel also works closely with the local science community, providing guidance and business support on a pro bono basis, as well as being involved with Lab13, an after-school science club, which focuses on making science exciting for children.

More information about Molecular Profiles’ award-winning services is available on their website, by e-mail at info[.]molprofiles.co.uk or call Dr. Nikin Patel on +44 115 8718888.

About Molecular Profiles

Molecular Profiles (molprofiles.co.uk) was founded in 1997 by a group of pharmaceutical scientists specialising in advanced characterisation of pharmaceutical and biological materials. Since then, the company has achieved a unique global position in pharmaceutical R&D and has developed a wide portfolio of pharmaceutical development services including formulation & analytical development and clinical trial manufacturing up to Phase IIa. The company is ideally placed to offer its clients a range of targeted solutions to help them to overcome the most challenging issues in drug development. Molecular Profiles’ contribution to the industry was acknowledged in 2007 and 2011 by the receipt of the Queens Award for Enterprise in the innovation category, the most prestigious business honour achievable in the UK.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: The Scott Partnership

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


CEO of Molecular Profiles Recognized as One of 100 Most Inspiring People in Life Sciences Industry

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

|
Publisher Contact: ScottPR.com 
+44 1477 539539 molecular[.]scottpr.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any The Scott Partnership securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From The Scott Partnership / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Newswires:

BD Announces Adoption of Windows 10 ‘Internet of Things’ for the Pyxis™ ES System
Greenphire Named to Deloitte 2016 Technology Fast 500™
Genentech Showcases New Clinical Data Across a Variety of Blood Diseases at American Society of Hematology 2016 Annual Meeting
BD Collaborates with JDRF to Focus on Extended Wear Innovations for Insulin Infusion Delivery
BD Launches First Syringe Designed for Use with Humulin® R U-500 Insulin
MDxHealth Announces Unique CPT Code Awarded for ConfirmMDx from the American Medical Association
BD MAX™ Vaginal Panel Receives FDA Market Authorization to Detect Most Common Causes of Vaginal Infections
Greenphire Receives EU-US Privacy Shield Certification
The 2016 Georges Mathé Prize Recognizes Research on the Immunological Determinants of the Response to Breast Cancer Treatment
MDxHealth Announces Agreement with HIFU CLINIC Prostate Cancer Center for Distribution of SelectMDx in Poland
First Patient in Malaysia Receives TheraSphere™ Radioembolisation Therapy
FDA Approves Genentech’s Lucentis® (Ranibizumab Injection) Prefilled Syringe
BTG and Mirada Medical Announce CE Mark Certification for Simplicit90Y Dosimetry Software in Europe
FDA Grants Priority Review to Genentech’s Lucentis® (Ranibizumab Injection) Supplemental Biologics License Application
Genentech’s TECENTRIQ® (Atezolizumab) Shows Significant Survival Advantage Compared to Chemotherapy

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  La Bella Bakery Artisan Bakery Arizona

Visit  Triggr & Bloom





 
  ©2016 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)